Kleo COVID-19 drug gets $5M from Gates Foundation
Kleo Pharmaceuticals, the five-year-old New Haven biotech based in Science Park, has secured a $5 million grant from the Bill & Melinda Gates Foundation for its...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Kleo Pharmaceuticals, the five-year-old New Haven biotech based in Science Park, has secured a $5 million grant from the Bill & Melinda Gates Foundation for its...
Cybrexa Therapeutics has successfully completed a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding its proposed IND and Phase I/II...
CRISPR methods have made genome engineering accurate and efficient. A team at The Jackson Laoratory led by Albert Cheng has developed a new method, CASFx,...
Arvinas reports that Wendy Dixon, Ph.D., has joined its Board of Directors. Dr. Dixon is a well-respected leader with 40 years of broad and deep...
As the coronavirus pandemic has reshuffled the economic landscape across the country, Connecticut is targeting small companies with top executives who may have grown tired...
Cybrexa Therapeutics has successfully completed a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding its proposed IND and Phase I/II...
Sema4 has ramped up the capacity for its coronavirus testing program to about 15,000 tests daily, an initiative praised by elected officials including U.S. Sen. Chris...
Boehringer Ingelheim has opened a site in Shanghai to connect its R&D, business development and venture capital groups to Chinese drug developers. The site brings...
Within six weeks of announcing a successful method to fabricate custom-fit mask frames to optimize protection from the spread of COVID-19, UConn has a licensing...
Branford diagnostics company Tangen Biosciences has won a contract from New York state’s health department to develop a point-of-care device to detect Candida auris, a...